Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-09-20
2005-09-20
McKenzie, Thomas C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S460000
Reexamination Certificate
active
06946459
ABSTRACT:
Two new crystalline forms of 1S-[1alpha(2S*, 3R*), 9alpha]6, 10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furany1)-9 [[(1-isoquinolyl) carbony1]amino]octahydro-6H-pyridazino [1,2-a][1,2]diazepin-1-carboxamide (anhydrous or hydrated), their preparation process and the pharmaceutical compositions containing them.
REFERENCES:
Randle, J.C. et al, Expert Opin. Investig. Drugs, 2001, vol. 10(7), pp. 1207-1209, Medline Abstract 11772244.
Giegel, D.A. et al, Ann. Reports Med. Chem., 33, 1998, 183-192.
Siegmund, B., Biochem. Pharmacol., vol. 64(1), 2002, pp. 1-8, Medline Abstract 12106600.
Godard Jean-Yves
Rognon Valerie
Aventis Pharma S. A.
Gupta Balaram
McKenzie Thomas C.
LandOfFree
CRYSTALLINE FORMS OF 1S-[1ALPHA(2S*,3R*), 9ALPHA]6,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CRYSTALLINE FORMS OF 1S-[1ALPHA(2S*,3R*), 9ALPHA]6,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CRYSTALLINE FORMS OF 1S-[1ALPHA(2S*,3R*), 9ALPHA]6,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3383866